IVD Procedure Volumes 2020-2025

26 Feb 2021

Categories:

SKU 21-015

In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama’s IVD Test Procedure Volumes, 2020-2025 saves time with calculations and estimates of the both the existing number of procedures for scores of diagnostic tests, and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD business planner.

IVD Test Procedure Volumes estimates IVD test procedure volume and IVD pricing for the following segments:

Worldwide IVD Market and Test Volume
Point-of-Care Market and Test Volume
Clinical Chemistry Market and Test Volume
Molecular Market and Test Volume
Hematology Market and Test Volume
Coagulation Market and Test Volume
Microbiology Market and Test Volume
Blood Screening Market and Test Volume
Histology/Cytology Market and Test Volume
Immunoassay Market and Test Volume
IVD Testing Segments and Global IVD Markets
The range of IVD procedures includes point-of-care and laboratory tests that are categorized according to the testing technology employed. Approximately 20 different technologies have been adapted to IVD applications. The pursuit of needed improvements in healthcare resources and capabilities will boost growth opportunities for IVD procedures and products in the majority of developing countries. The report provides the following IVD testing data points:

Table of Contents

One: Executive Summary
- IVD Procedure Volume Estimate and Forecast
  - COVID-19
- Scope & Methodology
- About Kalorama Information
Two: Introduction
- Industry Trends
  - COVID 19
Three: Healthcare Trends
- Overview
- Demographic Trends
  - Global Population and Aging
  - Workforce Reduction
  - Addressing the Aging Trend
  - Emerging and Emerged Markets
  - Emerging Nations and Health Insurance
Four: IVD Testing Segments
- IVD Testing Trends
- Segment Growth Projections
  - POC Testing
  - Clinical Chemistry
  - Immunoassays
  - Mass Spectrometry (Immuno)
  - Molecular Assays
  - Hematology
  - Coagulation
  - Conventional Microbiology
  - Mass Spectrometry (Micro)
  - Blood Grouping/Typing
  - Histology/Cytology
  - COVID 19
Five: Global IVD Markets
- General
- North America
  - United States
  - Canada
  - Mexico
- Central & South America
  - Brazil
  - Other Central & South America
- Western Europe
  - France
  - Germany
  - Italy
  - Spain
  - United Kingdom
  - Other Western Europe
- Eastern Europe
  - Russia
  - Other Eastern Europe
- Asia/Pacific
  - China
  - Japan
  - Other Asian Countries and Territories
- Middle East
  - Turkey
  - Other Middle East
- Africa
  - Egypt
Six: Point-of-Care (POC) Procedures
- Global POC Procedure Volume by Test Type
- POC Self Tests
  - Traditional Blood Glucose Monitoring Activities
  - Continuous Blood Glucose Monitoring
  - Fertility Testing
  - Coagulation Testing
  - Fecal Occult Blood Testing
  - Drugs of Abuse Testing
  - H. Pylori Testing
  - HIV Testing
  - Cholesterol Testing
  - POC Urinalysis Testing
  - Other POC Self-Testing
- POC Self-Testing Product Sales
- Pricing Trends
- POC Professional Testing
  - POC Professional Blood Glucose Testing Procedures
  - POC Professional Critical Care Testing
  - POC Fertility Testing
  - POC Professional Infectious Disease Testing
  - POC Professional Cardiac Marker Testing
  - POC Professional Cholesterol/Lipid Testing
  - POC Professional Coagulation Testing
  - POC Professional HbA1C Testing
  - POC Professional Hematology Testing
  - POC Professional Fecal Occult Blood Screening
  - POC Professional Drugs of Abuse Testing
  - POC Professional Urinalysis Testing
  - Other POC Professional Testing
- POC IVD Product Sales
- Pricing Trends
Seven: Clinical Chemistry Procedures
- Types of Tests
  - General Chemistry
  - Blood Gases & Electrolytes
  - Urinalysis
- Global Sales of Clinical Chemistry Products
- Pricing Trends
Eight: Immunoassay Procedures
- Technologies
- Labeling Techniques
  - Enzyme Immunoassays
  - Fluorescence Polarization Immunoassays (FPIAs)
  - Radioimmunoassays (RIAs)
- Testing Procedures & Product Sales
  - Cardiac Markers
  - Tumor Markers
  - Autoimmune Conditions
  - Allergy Conditions
  - Thyroid Conditions
  - Proteins
  - Anemia
  - Fertility Testing
  - Therapeutic Drug Monitoring
  - Vitamin D
  - Diabetes/HbA1c
  - Drugs of Abuse
  - Infectious Diseases
  - Blood Screening
  - COVID-19
- Instruments
- Pricing Trends
Nine: Molecular Testing Procedures
- Types of Test
  - Testing Technologies
  - Infectious Diseases
  - Blood Screening
  - Cancer
  - Transplant Matching
  - Thrombophilia SNPs
  - Inherited Diseases
  - Pharmacodiagnostic Tests
- Global Sales of Molecular IVD Products
- Pricing Trends
  - COVID 19
Ten: Hematology Procedures
- Types of Tests
- Global Sales of Hematology Products
- Pricing Trends
Eleven: Coagulation Testing Procedures
- Types of Tests
- Global Sales of Coagulation Products
- Pricing Trends
Twelve: Microbiology Procedures
- Types of Tests
  - ID/AST Automated Panels & Reagents
  - Manual Panels & Reagents
  - Blood Culture
  - Chromogenic Media
  - Rapid Microbiological Tests
  - Mass Spectrometry
- Global Sales of Conventional IVD Microbiology Products
  - ID/AST Panels & Reagents
  - Blood Culture
  - Chromogenic Media
  - Rapid Microbiological Tests
  - Mass Spectrometry
- Pricing Trends
Thirteen: Blood Grouping/Typing Procedures
- Types of Tests
- Blood Grouping/Typing Product Sales
- Pricing Trends
Fourteen: Histology/Cytology Procedures
- Types of Tests
  - Pap Tests
  - In Situ Hybridization Tests
  - Immunohistochemistry Tests
  - Traditional Non-Pap Stains
  - HPV
  - Circulating Tumor Cells
- Histology/Cytology IVD Product Sales
- Pricing Trends
Fifteen: Company Profiles
- Abbott Diagnostics
  - Recent Revenue History
  - Alere Acquisition Update and Point of Care
  - Core Lab
  - Hematology
  - Blood Banking
  - Infectious Diseases - Molecular
  - Diabetes
  - HIV Point of Care
  - i-STAT Business
  - COVID-19
- Becton, Dickinson and Company (BD)
  - Recent Revenue History
  - Cytology
  - Molecular Microbiology
  - Traditional Microbiology - ID/AST
  - Blood Culture
  - Hospital Acquired Infections
  - Blood Collection
  - Mass Spectrometry
  - Flow Cytometry
  - COVID-19
- bioMérieux Inc.
  - Recent Revenue History
  - Traditional Microbiology
  - Blood Culture
  - Immunoassays
  - BioFire Diagnostics Business
  - COVID-19
- Bio-Rad Laboratories, Inc.
  - Recent Revenue History
  - Blood Bank
  - Diabetes
  - Immunoassays
  - COVID-19
- Danaher Corporation
  - Beckman Coulter
  - Radiometer
  - Leica Biosystems
  - Cepheid
- Hologic, Inc.
  - Recent Revenue History
  - PANTHER Molecular System
  - HIV Testing
  - Sexually Transmitted Infections
  - Cytology
  - COVID-19
- Ortho Clinical Diagnostics (Ortho)
  - Recent Revenue History
  - Blood Bank
  - Core Lab / Immunoassays
  - COVID-19
- QIAGEN N.V.
  - Recent Revenue History
  - Tuberculosis
  - Molecular Expansion
  - Precision Medicine / Companion Diagnostics
  - Molecular Microbiology
  - Prenatal Testing
  - Next Generation Sequencing
  - Digital PCR
  - Liquid Biopsy
  - COVID-19
- Roche Diagnostics
  - Recent Revenue History
  - Hematology
  - Core Lab
  - Immunoassays
  - Core Molecular
  - Digital PCR
  - Diabetes Care
  - Coagulation
  - cobas Liat System – POC
  - HPV
  - Blood Bank
  - Cancer Companion Testing
  - COVID-19
- Siemens Healthineers (Siemens)
  - Recent Revenue History
  - Core Lab
  - Immunoassays
  - Hematology
  - Molecular
  - Acute Care – POC
  - COVID-19
- Sysmex Corporation
  - Recent Revenue History
  - Hematology
  - Coagulation
  - Urinalysis
  - Immunoassays
  - Flow Cytometry
  - Precision Medicine / Companion Test Diagnostics
  - Oncology
  - COVID-19
- Thermo Fisher Scientific Inc.
  - Recent Revenue History
  - Immunoassays
  - Microbiology
  - Next Generation Sequencing
  - qPCR
  - Mass Spectrometry
  - COVID-19

Attachments

21-015 2020-205 Procedure Volumes IVD.pdf